Table 1.

Demographic and clinical characteristics of HIV-1-seropositive and -seronegative subjects

Group and subjectaAge (yr)SexbRaceNo. of CD4+ T cells/mm3No. of HIV-1 RNA copies (log10 copies/ml)
HIV-1-seropositive subjects
    7740MCaucasian9135.26
    8726FCaucasian2564.36
    9034FBlack3324.86
    9136MBlack6914.49
    9529MHispanic9323.99
    10242FNative American6823.89
    10534MNative American5684.66
    10641MBlack7065.61
    11027MCaucasian6544.62
    11550MBlack7124.21
    11645FBlack2713.26
    11725FHispanic11174.35
    11829FBlack5883.62
    11929FCaucasian2573.85
    120*42FBlack3275.88
    121*36MBlack7204.26
    122*38FBlack4624.70
    12434FBlack8541.70
    12551FCaucasian3514.80
    12723FBlack5213.84
    12949FBlack5473.06
    13127MCaucasian5644.97
HIV-1-seronegative subjects
    7642FCaucasian
    8972MCaucasian
    9635MCaucasian
    9773MCaucasian
    10844FCaucasian
    10958FHispanic
  • a Asterisks denote the subjects who previously received antiretroviral therapy. At the time of enrollment in this study, they had been off therapy for 6 months or longer.

  • b M, male; F, female.